Meeting of the Advisory Committee on Infant Mortality, 29588 [2021-11504]

Download as PDF 29588 Federal Register / Vol. 86, No. 104 / Wednesday, June 2, 2021 / Notices HRSA specifically requests comments on: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2021–11542 Filed 6–1–21; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the Advisory Committee on Infant Mortality Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, this notice announces that the Advisory Committee on Infant Mortality (ACIM) has scheduled a public meeting. Information about ACIM and the agenda for this meeting can be found on the ACIM website at https://www.hrsa.gov/ advisory-committees/infant-mortality/ index.html. DATES: June 22, 2021, 12:00 p.m.–4:00 p.m. Eastern Time (ET) and June 23, 2021, 12:00 p.m.–4:00 p.m. ET. ADDRESSES: This meeting will be held via webinar. The webinar link and login information will be available at ACIM’s website before the meeting: https://www.hrsa.gov/advisorycommittees/infant-mortality/index.html. FOR FURTHER INFORMATION CONTACT: Vanessa Lee, MPH, Acting Designated Federal Official, Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane, Rockville, Maryland 20857; 301– 443–0543; or SACIM@hrsa.gov. SUPPLEMENTARY INFORMATION: The ACIM is authorized by section 222 of the Public Health Service Act (42 U.S.C. 217a), as amended. The Committee is governed by provisions of Public Law 92–463, as amended, (5 U.S.C. App. 2), which sets forth standards for the formation and use of Advisory Committees. The ACIM advises the Secretary of HHS on department activities and jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:49 Jun 01, 2021 Jkt 253001 programs directed at reducing infant mortality and improving the health status of pregnant women and infants. The ACIM represents a public-private partnership at the highest level to provide guidance and focus attention on the policies and resources required to address the reduction of infant mortality and the improvement of the health status of pregnant women and infants. With a focus on life course, the ACIM addresses disparities in maternal health to improve maternal health outcomes, including preventing and reducing maternal mortality and severe maternal morbidity. The ACIM provides advice on how best to coordinate myriad federal, state, local, and private programs and efforts that are designed to deal with the health and social problems impacting infant mortality and maternal health, including implementation of the Healthy Start program and maternal and infant health objectives from the National Health Promotion and Disease Prevention Objectives (i.e., Healthy People 2030). The agenda for the June 22–23, 2021, meeting is being finalized and may include the following topics: Discussion of recommendations by ACIM to the Secretary; updates from HRSA’s Maternal and Child Health Bureau, and other federal agencies; the Centers for Disease Control and Prevention’s Pregnancy Risk Assessment Monitoring System survey; and patient-physician racial concordance in health care. Agenda items are subject to change as priorities dictate. Refer to the ACIM website for any updated information concerning the meeting. Members of the public will have the opportunity to provide written or oral comments. Requests to submit a written statement or make oral comments to the ACIM should be sent to Vanessa Lee, using the email address above at least 3 business days prior to the meeting. Public participants may submit written statements in advance of the scheduled meeting by emailing SACIM@hrsa.gov. Oral comments will be honored in the order they are requested and may be limited as time allows. Individuals who plan to attend and need special assistance or another reasonable accommodation should notify Vanessa Lee at the contact information listed above at least 10 business days prior to the meeting. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2021–11504 Filed 6–1–21; 8:45 am] BILLING CODE 4165–15–P PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health. National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; Music and Health. Date: June 24, 2021. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Virtual Meeting). Contact Person: W. Ernest Lyons, PhD, Scientific Review Administrator, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Rockville, MD 20852, 301–496–4056, lyonse@ninds.nih.gov. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; Small Vessel VCID Biomarkers Validation Consortium Sites & Coordinating Center Review (U01 & U24). Date: June 25, 2021. Time: 10:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Virtual Meeting). Contact Person: Mir Ahamed Hossain, PhD, Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Rockville, MD 20852, 301–496–9223, mirahamed.hossain@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) E:\FR\FM\02JNN1.SGM 02JNN1

Agencies

[Federal Register Volume 86, Number 104 (Wednesday, June 2, 2021)]
[Notices]
[Page 29588]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11504]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Committee on Infant Mortality

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Committee on Infant Mortality (ACIM) 
has scheduled a public meeting. Information about ACIM and the agenda 
for this meeting can be found on the ACIM website at https://www.hrsa.gov/advisory-committees/infant-mortality/index.html.

DATES: June 22, 2021, 12:00 p.m.-4:00 p.m. Eastern Time (ET) and June 
23, 2021, 12:00 p.m.-4:00 p.m. ET.

ADDRESSES: This meeting will be held via webinar. The webinar link and 
log-in information will be available at ACIM's website before the 
meeting: https://www.hrsa.gov/advisory-committees/infant-mortality/index.html.

FOR FURTHER INFORMATION CONTACT: Vanessa Lee, MPH, Acting Designated 
Federal Official, Maternal and Child Health Bureau, HRSA, 5600 Fishers 
Lane, Rockville, Maryland 20857; 301-443-0543; or [email protected].

SUPPLEMENTARY INFORMATION: The ACIM is authorized by section 222 of the 
Public Health Service Act (42 U.S.C. 217a), as amended. The Committee 
is governed by provisions of Public Law 92-463, as amended, (5 U.S.C. 
App. 2), which sets forth standards for the formation and use of 
Advisory Committees.
    The ACIM advises the Secretary of HHS on department activities and 
programs directed at reducing infant mortality and improving the health 
status of pregnant women and infants. The ACIM represents a public-
private partnership at the highest level to provide guidance and focus 
attention on the policies and resources required to address the 
reduction of infant mortality and the improvement of the health status 
of pregnant women and infants. With a focus on life course, the ACIM 
addresses disparities in maternal health to improve maternal health 
outcomes, including preventing and reducing maternal mortality and 
severe maternal morbidity. The ACIM provides advice on how best to 
coordinate myriad federal, state, local, and private programs and 
efforts that are designed to deal with the health and social problems 
impacting infant mortality and maternal health, including 
implementation of the Healthy Start program and maternal and infant 
health objectives from the National Health Promotion and Disease 
Prevention Objectives (i.e., Healthy People 2030).
    The agenda for the June 22-23, 2021, meeting is being finalized and 
may include the following topics: Discussion of recommendations by ACIM 
to the Secretary; updates from HRSA's Maternal and Child Health Bureau, 
and other federal agencies; the Centers for Disease Control and 
Prevention's Pregnancy Risk Assessment Monitoring System survey; and 
patient-physician racial concordance in health care. Agenda items are 
subject to change as priorities dictate. Refer to the ACIM website for 
any updated information concerning the meeting.
    Members of the public will have the opportunity to provide written 
or oral comments. Requests to submit a written statement or make oral 
comments to the ACIM should be sent to Vanessa Lee, using the email 
address above at least 3 business days prior to the meeting. Public 
participants may submit written statements in advance of the scheduled 
meeting by emailing [email protected]. Oral comments will be honored in 
the order they are requested and may be limited as time allows.
    Individuals who plan to attend and need special assistance or 
another reasonable accommodation should notify Vanessa Lee at the 
contact information listed above at least 10 business days prior to the 
meeting.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021-11504 Filed 6-1-21; 8:45 am]
BILLING CODE 4165-15-P